Todd Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 23,025 shares at $24.71 ($569K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Scheduled sale ($569k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.71 | 11,478 | $284K | 49.8% |
| 2 | $24.71 | 11,478 | $284K | 49.8% |
| 3 | $25.40 | 69 | $2K | 0.3% |
| Total | $24.71 avg | 23,025 | $569K | 100% |
| Filing → |
| ARQT | SELL | 2026-03-03 | $1.9M | — | Filing → |
| ARQT | SELL | 2026-02-04 | $506K | — | Filing → |
| ARQT | SELL | 2025-11-24 | $3.0M | — | Filing → |